Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea

BACKGROUND/AIMS: Pegylated interferon (peginterferon) and ribavirin is the current standard therapy for chronic hepatitis C. The aims of this study were to evaluate the efficacy of peginterferon and ribavirin and to identify predictors of a sustained virological response (SVR) to the retreatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hyun Chin, Gwak, Geum-Youn, Paik, Yong Han, Choi, Moon Seok, Lee, Joon Hyeok, Koh, Kwang Cheol, Yoo, Byung Chul, Paik, Seung Woon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Pancreatobiliary Association; Korean Society of Gastrointestinal Cancer 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782674/
https://www.ncbi.nlm.nih.gov/pubmed/24073317
http://dx.doi.org/10.5009/gnl.2013.7.5.585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782674/
https://www.ncbi.nlm.nih.gov/pubmed/24073317
http://dx.doi.org/10.5009/gnl.2013.7.5.585

Ejemplares similares